Thirumala-Devi Kanneganti
Thirumala-Devi Kanneganti is an expert in Immunology at St. Jude Children's Research Hospital (United States). Thirumala-Devi Kanneganti has authored 418 publications, the most recent in 2026. SLR score: 2,447 (community average: 125). How the SLR is computed.
LeadR Profile
Immunology
Subspecialties: Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 418
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Innate immune sensors of inflammasomes and PANoptosomes: structural-mechanistic insights and therapeutic implications. PMID 42693250 | Cell Res | 2026 | 0 |
| IFN-α and IFN-β inhibit NLRP1-driven PANoptosis. PMID 42527629 — cells, molecular biology, macrophages, caspases, therapeutics, cell death | EMBO Rep | 2026 | 1 |
| Systematic genetic analysis of GSDMD, GSDME, and MLKL activation and execution of PANoptosis. PMID 42520933 — cells, biochemistry, neoplasms, pathology, inflammasomes, caspases, immunity, innate, cell death, membranes, infections | J Biol Chem | 2026 | 0 |
| NAD+ depletion links metabolic stress to drive innate immune priming and selectively control PANoptosis. PMID 42506907 — cells, hypersensitivity, stress, physiological, nad, therapeutics, cell death | J Immunol | 2026 | 1 |
| PANoptosis in life and death across cell types: From innate immunity to therapeutic implications. PMID 42462691 — cells, biochemistry, necroptosis, neoplasms, pathology, inflammasomes, caspases, immunity, pyroptosis, therapeutics, immunity, innate, apoptosis, cell death | Cell Chem Biol | 2026 | 0 |
LeadR Networks
Main global connection map